Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Financial Select Sector SPDR Fund (XLF) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance

Financial Select Sector SPDR FundTrade
DENTSPLY SIRONA IncTrade

Price performance (Past 24H)

Key statistics

Financial Select Sector SPDR Fund vs DENTSPLY SIRONA Inc — how do they compare? Financial Select Sector SPDR Fund trades at $54.59 (market cap $50.06B), while DENTSPLY SIRONA Inc trades at $8.82 (market cap $1.73B). The key difference: Financial Select Sector SPDR Fund is far larger — about 28.9× DENTSPLY SIRONA Inc's market cap, and DENTSPLY SIRONA Inc pays a 5.04% dividend while Financial Select Sector SPDR Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold Financial Select Sector SPDR Fund for 104 Days and DENTSPLY SIRONA Inc for 72 Days on average.

XLFXRAY
Market Cap
$50.06B$1.73B
Volume
47,464,1206,198,582
52-Week High
$58.55$14.68
52-Week Low
$47.80$8.52
Typical Hold Time
104 Days72 Days
Sector
—Health
Enterprise Value
—$3.80B
Dividend Yield
—5.04%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Financial Select Sector SPDR Fund

XLF trades at $54.48, up 1.36% with a bearish technical signal from moving averages. The ETF faces headwinds as financial stocks lag the S&P 500 by the widest margin since 1990 despite rising bank profits. Recent Fed stress test changes and interest rate hikes create both opportunities and challenges for financial sector performance.

The outlook remains cautious with technical indicators showing bearish momentum. Rising interest rates could benefit financial sector profitability, but regulatory uncertainty and market underperformance relative to broader indices present near-term risks for investors seeking financial sector exposure.

DENTSPLY SIRONA Inc

DENTSPLY SIRONA (XRAY) trades at $8.54, near its 52-week low, with bearish technical indicators and mixed fundamentals. The company reported Q2 2026 EPS of $0.52 beating expectations but revenue declined 4.1% year-over-year. Net income remains negative at -$598 million for 2025, though margins show slight improvement. Analyst consensus is mixed with 37.5% buy ratings but a $13.40 price target suggesting 57% upside potential from current levels.

The stock presents a high-risk turnaround opportunity with significant upside if management's restructuring efforts succeed, but faces headwinds from declining sales, margin pressure, and competitive challenges in dental markets. Institutional ownership changes and ongoing transformation investments create both uncertainty and potential for recovery.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

XLF
56% Buy44% Sell
Avg holding period · 104 Days
XRAY

No sentiment data available yet.

About Financial Select Sector SPDR Fund

The fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: diversified financial services; insurance; banks; capital markets; mortgage real estate investment trusts; consumer finance; thrifts; and mortgage finance. The fund is non-diversified.

Read more on XLF →

About DENTSPLY SIRONA Inc

Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters

Read more on XRAY →